⚠ BETA — all market data shown (deals, filings, prices, indices) is demo / illustrative, not live trading data. For evaluation only; verify before acting.
June 17, 2026
Investdesk

NSE

Astec LifeSciences LimitedASTEC

Astec LifeSciences Limited is an Indian pharmaceutical company involved in the manufacturing of APIs (Active Pharmaceutical Ingredients) and formulations.

Key productsAPIs, Formulations
GeographyIndia
CompetitorsDr Reddy's Laboratories, Cipla

AI-generated overview — verify before relying on it.

Net institutional flow

+₹0.4 Cr

Institutional buyers

3 in / 3 out

High-impact filings

0 · tilt Neutral

Next corporate action

Rights 1:7 @ Premium Rs 880/-

ex 2025-07-04

Competitive landscape — the read

vs most-traded names · ALL
1M3M6M1Y2YAll
Institutional money is backing ATALREAL hardest (+₹7.2 Cr net). ASTEC ranks #4 of 7 on flow (net buying +₹0 Cr).
#CompanyInst. flow ₹CrDealsHi-impactFiling mom.BuzzNews
1ATALREAL+₹7.2 Cr154————
2MOBIKWIK+₹0.1 Cr83————
3QUADFUTURE+₹0 Cr134————
4ASTECThis+₹0 Cr8————
5MTNL+₹0 Cr2————
6GATECH+₹0 Cr8————
7IRMENERGY−₹2.2 Cr328————

Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.

SWOT

Strengths

  • • Diversified portfolio with a strong presence in API manufacturing
  • • Established relationships with major pharmaceutical companies
  • • State-of-the-art manufacturing facilities
  • • Strong research and development capabilities

Weaknesses

  • • Dependence on a few key customers
  • • High operating costs due to regulatory compliance
  • • Competition from low-cost producers in emerging markets
  • • Limited presence in the US market

Opportunities

  • • Growing demand for generic APIs in emerging markets
  • • Increasing focus on sustainable and eco-friendly manufacturing practices
  • • Expansion into new product categories such as biosimilars
  • • Partnerships with pharmaceutical companies to develop new products

Threats

  • • Intensifying competition from generic drug manufacturers
  • • Regulatory changes and compliance risks
  • • Fluctuations in raw material prices and supply chain disruptions
  • • Economic downturn affecting consumer spending on healthcare

AI-generated from our data — verify before relying on it.

Timeline — ASTEC day by day

1M3M6M1Y2YAll
  1. 2026-05-18BulkBUY · ₹9.3 CrNK SECURITIES RESEARCH PRIVATE LIMITED
  2. 2026-05-18BulkSELL · ₹9.3 CrNK SECURITIES RESEARCH PRIVATE LIMITED
  3. 2026-05-18NetDay net −₹0 Cr
  4. 2026-04-10BulkSELL · ₹7.1 CrMANSI SHARE AND STOCK BROKING PRIVATE LIMITED
  5. 2026-04-10BulkBUY · ₹8.6 CrMANSI SHARE AND STOCK BROKING PRIVATE LIMITED
  6. 2026-04-10BulkBUY · ₹11.9 CrNK SECURITIES RESEARCH PRIVATE LIMITED
  7. 2026-04-10BulkSELL · ₹11.9 CrNK SECURITIES RESEARCH PRIVATE LIMITED
  8. 2026-04-10NetDay net +₹1.5 Cr
  9. 2026-03-25BulkSELL · ₹13.2 CrNK SECURITIES RESEARCH PRIVATE LIMITED
  10. 2026-03-25BulkBUY · ₹13.2 CrNK SECURITIES RESEARCH PRIVATE LIMITED
  11. 2026-03-25NetDay net +₹0 Cr
  12. 2025-12-09BulkSELL · ₹10.8 CrHRTI PRIVATE LIMITED
  13. 2025-12-09BulkBUY · ₹11.5 CrHRTI PRIVATE LIMITED
  14. 2025-12-09BulkSELL · ₹8.8 CrMATHISYS ADVISORS LLP
  15. 2025-12-09BulkBUY · ₹9 CrMATHISYS ADVISORS LLP
  16. 2025-12-09NetDay net +₹0.9 Cr
  17. 2025-12-03BulkSELL · ₹26 CrHRTI PRIVATE LIMITED
  18. 2025-12-03BulkBUY · ₹26.4 CrHRTI PRIVATE LIMITED
  19. 2025-12-03BulkSELL · ₹40.3 CrJUNOMONETA FINSOL PRIVATE LIMITED
  20. 2025-12-03BulkBUY · ₹40.3 CrJUNOMONETA FINSOL PRIVATE LIMITED
  21. 2025-12-03BulkSELL · ₹15.7 CrMUSIGMA SECURITIES
  22. 2025-12-03BulkBUY · ₹15.7 CrMUSIGMA SECURITIES
  23. 2025-12-03BulkBUY · ₹12.4 CrQE SECURITIES LLP
  24. 2025-12-03BulkSELL · ₹12.5 CrQE SECURITIES LLP
  25. 2025-12-03NetDay net +₹0.3 Cr
  26. 2025-12-01BulkBUY · ₹9 CrHRTI PRIVATE LIMITED
  27. 2025-12-01BulkSELL · ₹9.4 CrHRTI PRIVATE LIMITED
  28. 2025-12-01NetDay net −₹0.4 Cr
  29. 2025-11-28BulkBUY · ₹13 CrHRTI PRIVATE LIMITED
  30. 2025-11-28BulkSELL · ₹14.2 CrHRTI PRIVATE LIMITED
  31. 2025-11-28BulkBUY · ₹21.5 CrJUNOMONETA FINSOL PRIVATE LIMITED
  32. 2025-11-28BulkSELL · ₹21.6 CrJUNOMONETA FINSOL PRIVATE LIMITED
  33. 2025-11-28NetDay net −₹1.2 Cr
  34. 2025-11-27BulkBUY · ₹21.4 CrHRTI PRIVATE LIMITED
  35. 2025-11-27BulkSELL · ₹22.7 CrHRTI PRIVATE LIMITED
  36. 2025-11-27BulkBUY · ₹33.8 CrJUNOMONETA FINSOL PRIVATE LIMITED
  37. 2025-11-27BulkSELL · ₹33.8 CrJUNOMONETA FINSOL PRIVATE LIMITED
  38. 2025-11-27NetDay net −₹1.4 Cr
  39. 2025-07-04ActionRights 1:7 @ Premium Rs 880/-Rights
  40. 2024-07-23ActionAnnual General MeetingMeeting

Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.

Filings that matter

No scored filings for ASTEC yet.

Bulk & block deals

1M3M6M1Y2YAll

30 deals · 2025-11-27 → 2026-05-18

DateCounterpartyTypeSideValue
2026-05-18NK SECURITIES RESEARCH PRIVATE LIMITEDProp / churnBUY₹9.3 Cr
2026-05-18NK SECURITIES RESEARCH PRIVATE LIMITEDProp / churnSELL₹9.3 Cr
2026-04-10MANSI SHARE AND STOCK BROKING PRIVATE LIMITEDProp / churnSELL₹7.1 Cr
2026-04-10MANSI SHARE AND STOCK BROKING PRIVATE LIMITEDProp / churnBUY₹8.6 Cr
2026-04-10NK SECURITIES RESEARCH PRIVATE LIMITEDProp / churnBUY₹11.9 Cr
2026-04-10NK SECURITIES RESEARCH PRIVATE LIMITEDProp / churnSELL₹11.9 Cr
2026-03-25NK SECURITIES RESEARCH PRIVATE LIMITEDProp / churnSELL₹13.2 Cr
2026-03-25NK SECURITIES RESEARCH PRIVATE LIMITEDProp / churnBUY₹13.2 Cr
2025-12-09HRTI PRIVATE LIMITEDProp / churnSELL₹10.8 Cr
2025-12-09HRTI PRIVATE LIMITEDProp / churnBUY₹11.5 Cr

30 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.

News & chatter on ASTEC

RSS News

0

No recent news.

Google News RSS — links open the source.

Investdesk

0

No articles yet.

Our coverage.

Reddit

0

No Reddit chatter.

r/ posts mentioning the company.

Twitter / X

0

No posts.

Posts mentioning the company.